Granules India’s US facility clears FDA inspection with zero issues; stock moves up 4%Granules India’s US facility clears FDA inspection with zero issues; stock moves up 4%

Introduction

Leading pharmaceutical firm’s US subsidiary receives FDA No Action Indicated status for its Manassas packaging facility, managing OTC and prescription product packaging and distribution across the United States.

Also Read: HAL bags MoD contract for 6 ALH Mk III helicopters; contracts worth ₹2,901 Cr

Share price movement of Granules India

On March 5, 2026, Granules India Ltd opened at ₹554.55, up 0.91% from its previous close of ₹553.50. The stock reached a high of ₹572.95 (3.44%) and a low of ₹554.55. By 3:15 PM, it traded at ₹572.30, a 3.40% increase, with a market cap of ₹13,887.93 crore.

Granules India US Facility Cleared

Granules India Limited’s US subsidiary, Granules Consumer Health, LLC, received an Establishment Inspection Report with No Action Indicated status from the US FDA at Manassas facility.

The FDA inspection occurred from December 1 to 3, 2025. This is the facility’s second audit, following a March 2023 inspection, which also concluded with zero observations.

The Manassas facility packages both OTC and prescription products. It serves as a distribution hub for OTC products across the US, leveraging Granules India’s manufacturing and supply chain efficiencies.

Stock performance of Granules India for period of 1 week, 6 months, and 1 year

Granules India Ltd delivered a -6.20% return over the past week, gained 8.40% in the past 6 months, and rose 14.6% over the past 1 year.

Also Read: Shanti Educational Initiatives: Stock gains after company to merge with solar player Grew Energy

Shareholding pattern of Granules India

Particulars	Dec 2025	Sep 2025	Jun 2025
Promoter	38.80%	38.80%	39%
FII	13.60%	14.10%	13.20%
DII	18%	17.90%	24%
Public	30%	29%	24%

About Granules India

Granules India Ltd (NSE: GRANULES) is a vertically integrated pharmaceutical company from Hyderabad, producing APIs, PFIs, FDs, and peptides, serving over 80 countries with 11 global facilities.

Stay Ahead with the Latest Stock Market Updates – Click Here

Disclaimer: The above article is written for educational purposes, and the companies’ data mentioned in the article may change with respect to time. The securities quoted are exemplary and are not recommendatory.

FAQs